A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis
Clinical trial NCT03468556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03468556
- Sponsor
- Sinew Pharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-04-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.